HYLO-Forte
Commercial- Indications
- Dry eye disease
Company intelligence / Profile preview
Scope Ophthalmics
Crawley, England, United Kingdomscopeeyecare.com ↗
- Ownership
- Private
- Employees
- ~175
- Development stage
- Commercial
01
Overview
Scope Ophthalmics sells commercially available, preservative-free eye care products (e.g., drops, wipes, supplements) for ocular surface diseases in the UK, Ireland, USA, and other select markets. The company does not appear to conduct clinical trials for novel drug candidates but focuses on product innovation, market leadership in dry eye segments, and expansion into allergy and glaucoma supportive care[1][6].
- Therapeutic areas
- Ophthalmology
- Modalities
- DeviceSmall moleculeFood supplement
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Scope Ophthalmics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Scope Ophthalmics.